🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Status
Recruiting
Location
Cedars-Sinai Women's Heart Center
Start Date
2015-10
Trial ID
NCT02582021
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
This randomized phase III trial studies how well pazopanib hydrochloride wo...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2012-08-08
Trial ID
NCT01575548
Aim and objectives: This trial aims to evaluate the role of adjuvant radio...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Start Date
2016-06-02
Trial ID
NCT02951325
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791